You can buy or sell Lantern Pharma and other stocks, options, ETFs, and crypto commission-free!
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-11, LP-300, and LP-184. Read More The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX. The listed name for LTRN is Lantern Pharma Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Oct 29, Pre-Market